Trial Profile
Clinical Study of Apatinib Mesylate in the Treatment of Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2020
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 08 Jun 2018 New trial record